Jianhua SUI

Person

Beijing, CN

People

Patents Applicationslast 30 patents

Information Patent Application
BI-FUNCTIONAL FUSION PROTEIN AND USES THEREOF
- Publication number 20240391990
- Publication date Nov 28, 2024
- PULMONGENE (HONG KONG) CO., LIMITED
- Nan TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A BISPECIFIC ANTIBODY TARGETING GPC3 AND CD47
- Publication number 20240076412
- Publication date Mar 7, 2024
- NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
- Jianhua SUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBLE ACE2 AND FUSION PROTEIN, AND APPLICATIONS THEREOF
- Publication number 20230348880
- Publication date Nov 2, 2023
- NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
- Wenhui Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED DISEASES
- Publication number 20230272067
- Publication date Aug 31, 2023
- Huahui Health Ltd.
- Jianhua SUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST AREG AND ITS USE
- Publication number 20230041071
- Publication date Feb 9, 2023
- NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
- Jianhua Sui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A METHOD OF TREATING HBV INFECTION BY USING ANTI-PRE-S1 HBV ANTIBODIES
- Publication number 20220259292
- Publication date Aug 18, 2022
- Huahui Health Ltd.
- Wenhui LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-FGF19 ANTIBODIES
- Publication number 20220041706
- Publication date Feb 10, 2022
- Huahui Health Ltd.
- Jianhua SUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jianhua SUI

Person

Patents Applicationslast 30 patents

BI-FUNCTIONAL FUSION PROTEIN AND USES THEREOF

A BISPECIFIC ANTIBODY TARGETING GPC3 AND CD47

SOLUBLE ACE2 AND FUSION PROTEIN, AND APPLICATIONS THEREOF

HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED DISEASES

ANTIBODIES AGAINST AREG AND ITS USE

A METHOD OF TREATING HBV INFECTION BY USING ANTI-PRE-S1 HBV ANTIBODIES

ANTI-FGF19 ANTIBODIES